You are viewing: US Single-use Bioprocessing Market analysis

The US Single-use Bioprocessing Market was valued at $2058.9 Million in 2025 and projected to reach to $3610.3 Million by 2030, representing a compound annual growth rate of 11.9%. The US single-use bioprocessing market is positioned for sustained growth through 2030, driven by the biopharmaceutical industry's shift toward flexible, cost-effective manufacturing solutions.

US Single-use Bioprocessing Market Trends and Insights

  • The US market benefits from strong biopharmaceutical manufacturing infrastructure, regulatory support, and increasing adoption of single-use technologies by major pharmaceutical and biotechnology companies.
  • The US dominates North America's bioprocessing landscape, driven by demand for cost-effective, flexible manufacturing solutions that reduce contamination risk and operational complexity. In the US, single-use bioprocessing systems are increasingly preferred for vaccine production, monoclonal antibody manufacturing, and cell therapy applications.
  • The market expansion from 2025 to 2030 reflects growing investment in biomanufacturing capacity, accelerated by supply chain resilience initiatives and the shift toward modular production platforms.
  • The US regulatory environment, led by the FDA, continues to support innovation in single-use technologies, enabling faster product approvals and manufacturing scale-up..

Key Market Statistics

  • CAGR (2025-2030) 11.9% CAGR
  • Market Size, 2025 ~USD 2058.9 Million
  • Forecast, 2030 ~USD 3610.3 Million
  • Country US

US Single-use Bioprocessing Market Overview

Market Valuation :

The US single-use bioprocessing market is valued at $2,058.9 million in 2025, with strong growth trajectory driven by domestic biopharmaceutical manufacturing expansion and FDA regulatory support for innovative bioprocessing technologies.

Robust Growth Trajectory :

The US market is projected to reach $3,610.3 million by 2030, representing an 11.9% CAGR. This growth outpaces many developed markets due to increased adoption by major US pharmaceutical and biotechnology companies seeking operational efficiency.

Manufacturing Infrastructure Advantage :

The US benefits from world-class biopharmaceutical manufacturing infrastructure, established supply chains, and a concentration of leading biotech companies in regions like California, Massachusetts, and North Carolina driving single-use technology adoption.

Regulatory and Innovation Support :

FDA support for single-use bioprocessing systems, combined with US companies' focus on reducing manufacturing costs and improving flexibility, accelerates market penetration across contract manufacturing organizations and in-house pharma operations.

US Single-use Bioprocessing Market Dynamics

  • Major US pharmaceutical and biotechnology companies are increasingly adopting single-use technologies to reduce capital expenditure, minimize contamination risks, and accelerate time-to-market for new therapeutics.
  • The FDA's supportive regulatory environment and emphasis on manufacturing innovation further bolster market expansion. Key growth drivers include rising demand for personalized medicine, increased outsourcing to contract manufacturing organizations, and the need for rapid scale-up capabilities in response to global health challenges.
  • The US market's maturity and technological sophistication position it as a leader in single-use bioprocessing adoption, with continued investment in R&D and manufacturing facility upgrades expected to sustain the 11.9% CAGR through 2030..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The US single-use bioprocessing market will grow from $2,058.9M (2025) to $3,610.3M (2030) at an 11.9% CAGR.
    • The US market is driven by biopharmaceutical companies seeking flexible, contamination-free manufacturing solutions.
    • FDA regulatory support in the US accelerates adoption of single-use technologies across vaccine and cell therapy production.
    • The US market expansion reflects increased investment in domestic biomanufacturing capacity and supply chain resilience.

    Single-use Bioprocessing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONSUMABLES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 13.3% from 2025 to 2030
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 18.03 (2025)
    Revenue Forecast (Billions) ~USD 33.67 (2030)
    Segments Covered Product, Type, Scale Range, Scale

    US Single-use Bioprocessing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Equipment

    By Type

    • 2D Bags & Containers
    • 3D Bags & Containers
    • Bag Assemblies
    • Bottle Assemblies
    • Filtration Assemblies
    • Mixing System Assemblies
    • Other Assemblies
    • Other Single-Use Consumables
    • Other Single-Use Equipment
    • Single-Use Assemblies
    • Single-Use Bags & Containers
    • Single-Use Bioreactors
    • Single-Use Chromatography Columns
    • Single-Use Chromatography Systems
    • Single-Use Filters
    • Single-Use Filtration Systems
    • Single-Use Mixing Systems
    • Single-Use Sensors

    By Scale Range

    • 101–500 L Bioreactors
    • 11–100 L Bioreactors
    • 501–1,500 L Bioreactors
    • >1,500 L Bioreactors
    • =10 L Bioreactors

    By Scale

    • Manufacturing-Scale Filtration Systems
    • Manufacturing-Scale Mixing Systems
    • Pilot-Scale Filtration Systems
    • Pilot-Scale Mixing Systems
    • R&D-Scale Filtration Systems
    • R&D-Scale Mixing Systems

    Target Audience

    • Biopharmaceutical Manufacturers : US-based pharma and biotech companies need this data to evaluate single-use technology adoption ROI, benchmark manufacturing efficiency, and make capital investment decisions aligned with market growth trends.
    • Contract Manufacturing Organizations (CMOs) : CMOs operating in the US require market insights to assess demand for single-use bioprocessing services, plan facility expansions, and position themselves competitively as clients increasingly outsource manufacturing.
    • Equipment & Technology Suppliers : Manufacturers of single-use bioreactors, filtration systems, and bioprocessing equipment need US-specific market data to identify growth opportunities, target key accounts, and develop region-tailored product strategies.
    • Private Equity & Investment Firms : Investors evaluating bioprocessing companies or manufacturing assets require validated US market forecasts and growth drivers to assess investment returns and identify acquisition targets in this high-growth sector.
    • Regulatory & Compliance Consultants : Consultants advising biotech clients on manufacturing strategy need US market context, FDA regulatory trends, and adoption patterns to provide informed guidance on single-use technology implementation and compliance.

    Key Companies in the US Single-use Bioprocessing Market

    CompanyHQOwnershipStrongest segments

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise US market valuation ($2,058.9M in 2025) and verified forecast data ($3,610.3M by 2030) to support strategic planning, investment decisions, and competitive positioning in the American bioprocessing sector.
    • Regional Competitive Intelligence : Understand US-specific market dynamics, identify leading manufacturers and adopters, and benchmark your company's performance against domestic competitors to optimize market entry or expansion strategies.
    • Regulatory & Infrastructure Insights : Gain detailed knowledge of FDA regulatory landscape, manufacturing infrastructure advantages, and regional concentration of biotech hubs to inform product development and go-to-market strategies tailored to US requirements.
    • Investment & Partnership Opportunities : Identify high-growth segments, emerging partnerships between pharma and CMOs, and investment hotspots across US regions to guide capital allocation and strategic collaboration decisions.
    • Demand Forecasting & Planning : Leverage the 11.9% CAGR projection and segment-specific growth drivers to forecast demand, plan production capacity, and allocate resources effectively for the US market through 2030.

    Frequently asked questions

    What is the current size of the US single-use bioprocessing market?

    The US single-use bioprocessing market is valued at $2,058.9 million in 2025.

    What is the projected size of the US market by 2030?

    The US single-use bioprocessing market is projected to reach $3,610.3 million by 2030.

    What is the growth rate of the US single-use bioprocessing market?

    The US market is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030.

    Which applications drive the US single-use bioprocessing market?

    The US market is primarily driven by vaccine production, monoclonal antibody manufacturing, and cell therapy applications.

    Why is the US adopting single-use bioprocessing technologies?

    The US biopharmaceutical industry adopts single-use technologies for cost efficiency, reduced contamination risk, manufacturing flexibility, and faster product scale-up.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

    These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

    The following is a breakdown of the primary respondents:

    Single-use Bioprocessing Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.

    Single-use Bioprocessing Market

    Data Triangulation

    After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

    Stakeholders

    • Single-use bioprocessing equipment and consumables manufacturing companies
    • Single-use bioprocessing equipment and consumables distributors
    • Pharmaceutical and biotechnology companies
    • Contract manufacturing companies (CMOs)
    • Contract research organizations (CROs)
    • Academic and research institutes
    • Life science companies
    • Market research and consulting firms
    • Venture capitalists and investors
    • Government organizations
    • Private research firms

    Report Objectives

    • To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
    • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
    • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
    • To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

     

    Get the Full Single-use Bioprocessing Market Report

    Full forecast, segment splits, and company analysis for all Single-use Bioprocessing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status